Aortic Stenosis Treatment Market Trends

Request Free Sample Copy

Report ID: 3125
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Buy Now

Aortic Stenosis Treatment Sector: Growth Drivers and Challenges

Growth Drivers

Increasing Prevalence of Valvular Heart Diseases
Rising Investment to Develop New Treatment Solutions

Challenges

High Cost of Treatment

Aortic Stenosis Treatment Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	9.5%
Base Year Market Size (2024)	USD 7.57 billion
Forecast Year Market Size (2037)	USD 24.63 billion
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Aortic Stenosis Treatment Market Size & Share, Growth Analysis 2037

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of aortic stenosis treatment is assessed at USD 8.18 billion.

Aortic Stenosis Treatment Market size was valued at USD 7.57 billion in 2024 and is expected to reach USD 24.63 billion by 2037, registering around 9.5% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is predicted to hold largest revenue share by 2037, on the back of high cases of valve diseases in the region.

The major players in the market are Edwards Lifesciences Corporation, Neovasc Inc., HighLife SAS, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, CryoLife Inc., Siemens Healthcare GmbH, and others.